{"paper_id":"9c0abbc8-3a78-4fb4-b93a-39a984e13e3a","body_text":"Abstract\nGynecologic pathology is the subspecialty of surgical pathology that studies and makes diagnoses of diseases of the female genital tract. Some gynecologic pathologists include breast pathology in their subspecialty practice while others focus only on the organs that form part of the female genital tract from the vulva to the ovaries and fallopian tubes. Gynecologic pathologists work closely with gynecologists and radiologists in their subspecialty areas to make diagnoses of difficult and unusual cases. Many studies have shown that sex hormones such as estrogens and specific subtypes of viruses are implicated in the pathogenesis of vaginal and cervical cancers. Studies on the pathogenesis and manifestation of these conditions by pathologists, gynecologists, and other researches have supported these observations. Some of the topics discussed in this chapter include: clear cell adenocarcinoma of the vagina and cervix, carcinoma of the cevix, endometrial adenocarcinoma, serous ovarian carcinoma, and endometriosis.\nAccess this chapter\nTax calculation will be finalised at checkout\nPurchases are for personal use only\nSimilar content being viewed by others\nReferences\nHerbst AL, Cole P, Norusis MJ, et al. Epidemiologic aspects and factors related to survival in 384 registry cases of clear cell adenocarcinoma of the vagina and cervix. AJ Obstet Gynecol. 1979;135(7):876–86.\nHerbst AL, Scully RE. Adenocarcinoma of the vagina in young women. A report of 7 cases including clear cell carcinomas (so-call mesonephromas). Cancer. 1970;25:745–57.\nHerbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. New Engl J Med. 1971;284(15):878–81.\nRobboy SJ, Young RH, Welch NR, et al. Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring. Cancer. 1984;54(5):869–75.\nStoler MH. Human papilloma virus and cervical neoplasia. Human papilloma virus and cervical neoplasia: a model for carcinogenesis. Int J Gynecol Pathol. 2006;19:16–28.\nThompson J 3rd, Thomas LK, Shroyer KP. Human papilloma virus: molecular and cytologic/histologic aspects related to cervical intraepithelial neoplasia and carcinoma. Hum Pathol. 2008;39:54–166.\nNuovo CJ. Human papilloma virus DNA in genital tract lesions histologically negative for condyloma. Analysis by in situ, southern blot hybridization and the polymerase chain reaction. Am J Surg Pathol. 1990;14:643–51.\nMiller RA, Waters LL, Mody DR, et al. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in Chinese practice. Arch Pathol Lab Med. 2015;139(6):776–81.\nStelzle D, Tanaka LF, Lee KK, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021;9(2):e161–9.\nCastle PE, Xie X, Xue X, et al. Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results. Prev Med. 2019;118:44–50.\nNoumoff JS, Faruqi S. Endometrial adenocarcinoma. Microsc Res Tech. 1993;25(3):246–54.\nSanderson PA, Critchley HOD, Williams ARW. New concepts of an old problem: the diagnosis of endometrial hyperplasia. Hum Reprod Update. 2017;23(2):232–54.\nGibson DA, Simitsidellis I, Collins F, Sanders PTK, Androgens, oestrogens and endometrium. A fine balance between perfection and pathology. J Endocrinol. 2020;246(3):R75–93.\nFeeley KM, Wells M. Precursor lesions of ovarian epithelial malignancy. Histopathology. 2001;38:87–95.\nCrum CP, Drapkin R, Kindelberger D, et al. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res. 2007;5:35–44.\nSalvador S, Gilks B, Kobel M, et al. The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int J Gynecol Cancer. 2009;19:58–64.\nLisio M-A, Fu L, Goyereche A, et al. High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints. Int J Mol Sci. 2019;20(4):952–6.\nKindelberger DW, Lee Y, Miron A, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma. Evidence for a causal relationship. Am J Surg Pathol. 2007;31:161–9.\nNetwork GGAR. Integrated genomic analysis of ovarian carcinoma. Nature. 2011;474:609–15.\nVercellini P, Vigano P, Somigliana E, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10:261–75.\nAnglesio MS, Papadopoules N, Aylan A, et al. Cancer-associated mutations in endometriosis without cancer. N Engl J Med. 2017;376(19):1835–48.\nWei JJ, William J, Bulun S. Endometriosis and ovarian cancer: a review of clinical, pathologic and molecular aspects. Int J Gynecol Pathol. 2011;30:553–68.\nYoung RH. Scully, Robert E. (1921-2012). In: Louis DN, Young RH, editors. Keen minds to explore the dark continents of disease. A history of the pathology service at the Massachusetts General Hospital. Boston: Mass Gen Hospital & Harvard Medical School; 2011. p. 134–46.\nYoung RH, Scully, Robert E. (1921–2012). In: van den Tweel JG, editor. Pioneers in pathology. In: van Krieken JHJM, series editor. Encyclopedia of pathology. Cham:Springer; 2017. pp. 479–481.\nYoung RH, Mills SE, Wick MR. In memoriam. Robert E. Scully, MD 1921-2012. Am J Clin Pathol. 2013;139:126.\nTalerman A, Robert Scully MD. A pathologist’s perspective. Hum Pathol. 1991;22(8):747–9.\nYoung RH. Robert Scully MD. Am J Surg Patholog. 2013;37:464–8.\nYoung RH, Oliva E, Scully RE. Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases. Am J Surg Pathol. 1994;18:1102–16.\nScully RE. Gonadoblastoma. A review of 74 cases. Cancer. 1970;25:1340–56.\nYoung RH, Dickerson GR, Scully RE. Juvenile granulosa cell tumor of the ovary. A clinicopathological study of 125 cases. Am J Surg Pathol. 1984;8:575–96.\nYoung RH, An interview of Robert J Kurman, MD. Learning, teaching, passing the torch. Int J Gynecol. Pathology. 2018;37(1):1–16.\nKurman RJ, Young RH, Main CS, et al. Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors with emphasis on intermediate trophoblast and the placental site trophoblastic tumor. Int J Gynecol Pathol. 1984;3:101–21.\nShih I-M, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004;164:1511–8.\nKurman RJ, Shih I-M. The dualistic model of ovarian carcinogenesis. Revisited, revised and expanded. Am J Pathol. 2016;186:733–47.\nKurman RJ, Shih I-M. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer – shifting the paradigm. Hum Pathol. 2011;42(7):918–31.\nAuthor information\nAuthors and Affiliations\nRights and permissions\nCopyright information\n© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG\nAbout this chapter\nCite this chapter\nLloyd, R.V. (2023). Gynecologic Pathology. In: Pathology: Historical and Contemporary Aspects. Springer, Cham. https://doi.org/10.1007/978-3-031-39554-3_6\nDownload citation\nDOI: https://doi.org/10.1007/978-3-031-39554-3_6\nPublished:\nPublisher Name: Springer, Cham\nPrint ISBN: 978-3-031-39553-6\nOnline ISBN: 978-3-031-39554-3\neBook Packages: MedicineMedicine (R0)","source_license":"CC0","license_restricted":false}